Bessemer Group
INFI

Bessemer Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bessemer Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-61,888
Closed -$84K – 1947
2016
Q4 		$84K Hold
61,888
– – ﹤0.01% 1252
2016
Q3 		$97K Hold
61,888
– – ﹤0.01% 1111
2016
Q2 		$82K Hold
61,888
– – ﹤0.01% 793
2016
Q1 		$326K Hold
61,888
– – ﹤0.01% 620
2015
Q4 		$486K Buy
+61,888
New +$533K ﹤0.01% 627

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Bessemer Group's INFI Position: Q1 2017 in Review

Bessemer Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2017, closing a stake of 61,888 shares — an estimated $84K sold.

Bessemer Group first reported a position in INFI in Q4 2015 and held it in 5 quarters. The position peaked at $486K in Q4 2015. 80 funds tracked by Wall St. Rank hold INFI as of Q1 2017.

  • Bessemer Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Bessemer Group sold 61,888 Infinity Pharmaceuticals, Inc. shares in Q1 2017, an estimated $84K.
  • Bessemer Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2015 and held it in 5 quarters.
  • Bessemer Group's Infinity Pharmaceuticals, Inc. position peaked at $486K in Q4 2015.
  • 80 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2017.

Based on Bessemer Group's 13F filing for Q1 2017, filed 12 May 2017.